O1M Stock Overview
Provides solutions and services to pharmacies and pharmaceutical companies in Canada.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
KDA Group Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.18 |
52 Week High | CA$0.41 |
52 Week Low | CA$0.048 |
Beta | 1.24 |
11 Month Change | 24.16% |
3 Month Change | 4.52% |
1 Year Change | 255.77% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 262.04% |
Recent News & Updates
Recent updates
Shareholder Returns
O1M | DE Healthcare | DE Market | |
---|---|---|---|
7D | -1.1% | -1.5% | 0.8% |
1Y | 255.8% | 23.5% | 14.0% |
Return vs Industry: O1M exceeded the German Healthcare industry which returned 23.5% over the past year.
Return vs Market: O1M exceeded the German Market which returned 14% over the past year.
Price Volatility
O1M volatility | |
---|---|
O1M Average Weekly Movement | 14.2% |
Healthcare Industry Average Movement | 3.6% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 10.5% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: O1M's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: O1M's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | n/a | Marc Lemieux | groupekda.ca |
KDA Group Inc., together with its subsidiaries, provides solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates through three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. It provides pharmacy staff replacement services, professional and continued medical training services, pharmacy re-engineering services, and pharmaceutical training services.
KDA Group Inc. Fundamentals Summary
O1M fundamental statistics | |
---|---|
Market cap | €33.83m |
Earnings (TTM) | -€586.44k |
Revenue (TTM) | €135.70k |
249.3x
P/S Ratio-57.7x
P/E RatioIs O1M overvalued?
See Fair Value and valuation analysisEarnings & Revenue
O1M income statement (TTM) | |
---|---|
Revenue | CA$204.14k |
Cost of Revenue | CA$0 |
Gross Profit | CA$204.14k |
Other Expenses | CA$1.09m |
Earnings | -CA$882.18k |
Last Reported Earnings
Apr 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.005 |
Gross Margin | 100.00% |
Net Profit Margin | -432.15% |
Debt/Equity Ratio | 6.4% |
How did O1M perform over the long term?
See historical performance and comparison